A novel diagnostic androgen receptor gene signature links clinical outcomes and preclinical response to enzalutamide, paclitaxel or the combination in triple -negative breast cancer

作者:Phan V T; Protter A A; Peterson A C; Parker J S; Yoon K; Tudor I C; Paton V; Noonberg S; Uppal H
来源:38th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2015-12-08 To 2015-12-12.
DOI:10.1158/1538-7445.SABCS15-P2-07-04
  • 出版日期2016-2-15

全文